CDK12 and colorectal carcinoma: In keeping with this role, we found that CDK12 inhibition by the compound SR‐4835 for 6 h or specific shRNA led to a evident decrease in S2 phosphorylation of RNA Pol II CTD with a minimal effect on the transcription initiation‐associated S5 in CRC cells (Figure 3A,B).